IMMP

1.74

0.58% 0.01

Dopo l'orario di chiusura: 1.81 0.07 +4.02%

Immutep Limited Adr (IMMP)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$1.73

Aprire:

$1.74

Volume 24 ore:

46,848

Relative Volume:

0.17

Capitalizzazione di mercato:

$270.74M

Reddito:

Utile/perdita netta:

Rapporto P/E:

-7.7437

EPS:

-0.2247

Flusso di cassa netto:

1 W Prestazione:

-6.45%

1M Prestazione:

-7.94%

6M Prestazione:

-20.18%

1 anno Prestazione:

-36.26%

Intervallo 1D:

$1.71

$1.80

Intervallo di 1 settimana:

$1.71

$1.92

Portata 52W:

$1.32

$2.80

Immutep Limited Adr Stock (IMMP) Company Profile

Nome

Immutep Limited Adr

Settore

Healthcare (1168)

Industria

Biotechnology (661)

Telefono

Indirizzo

Dipendente

Cinguettio

Prossima data di guadagno

2025-02-24

Ultimi documenti SEC

IMMP's Discussions on Twitter

Confronta IMMP con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IMMP Immutep Limited Adr	1.74	270.74M	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	455.45	115.69B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	529.24	53.25B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	307.99	39.22B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	577.89	35.78B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	269.63	27.68B	3.81B	-644.79M	-669.77M	-6.24

Immutep Limited Adr Stock (IMMP) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-05-17	Iniziato	CapitalOne	Overweight
2023-08-03	Iniziato	Robert W. Baird	Outperform
2021-08-03	Iniziato	Ladenburg Thalmann	Buy
2021-07-16	Ripresa	Maxim Group	Buy
2018-09-28	Iniziato	B. Riley FBR	Buy
2018-02-15	Reiterato	Maxim Group	Buy

Mostra tutto

Immutep Limited Adr Borsa (IMMP) Ultime notizie

Jun 08, 2025

Jane Street Group LLC Has $98,000 Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Jun 08, 2025

Jun 01, 2025

Immutep Ltd Highlights Immune System Innovations at Healthcare Conference - TipRanks

Jun 01, 2025

May 08, 2025

Market Highlights: Immutep Limited ADR (IMMP) Ends on a Low Note at 1.93 - DWinneX

May 08, 2025

May 06, 2025

Immutep stock soars on promising trial results - Investing.com Australia

May 06, 2025

May 05, 2025

Immutep stock soars on promising trial results By Investing.com - Investing.com Nigeria

May 05, 2025

Apr 29, 2025

Immutep Quarterly Activities Report Q3 FY25 - The Manila Times

Apr 29, 2025

Apr 02, 2025

Immutep to Participate in Upcoming Investor Conferences - GlobeNewswire Inc.

Apr 02, 2025

Mar 24, 2025

Immutep Limited (ASX:IMM) Initiates Phase III Trial for Non-Small Cell Lung Cancer - thecapitalclub.com.au

Mar 24, 2025

Feb 11, 2025

Is Immutep Limited (IMMP) the Best Long Term ASX Stock to Buy Now? - AInvest

Feb 11, 2025

Jan 14, 2025

Immutep Limited (NASDAQ:IMMP) Shares Sold by Jane Street Group LLC - Defense World

Jan 14, 2025

Dec 18, 2024

Verition Fund Management LLC Has $57,000 Stock Position in Immutep Limited (NASDAQ:IMMP) - Defense World

Dec 18, 2024

Dec 17, 2024

Immutep Announces Initial Safety Data from First-in-Human Phase I Trial Evaluating IMP761 - The Manila Times

Dec 17, 2024

Dec 12, 2024

Immutep shares new cancer study results - Investing.com

Dec 12, 2024

Oct 29, 2024

Immutep Quarterly Activities Report Q1 FY25 - Yahoo Finance

Oct 29, 2024

Oct 17, 2024

Immutep Announces First-in-Human Phase I Study of IMP761 Progresses to Dose Escalation Portion of Trial - Yahoo Finance

Oct 17, 2024

Apr 18, 2024

Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761 - GlobeNewswire

Apr 18, 2024

Feb 05, 2024

10 Best Australian Stocks To Buy - Yahoo Finance

Feb 05, 2024

Nov 27, 2023